Skip to main content
Fig. 4 | Stem Cell Research & Therapy

Fig. 4

From: Safety, efficacy and biomarkers analysis of mesenchymal stromal cells therapy in ARDS: a systematic review and meta-analysis based on phase I and II RCTs

Fig. 4

Forest plot of mortality. Mortality was not statistically significant between the two groups, either at short-term or long-term follow-up. No significant heterogeneity was observed in any of the five groups, and a fixed-effects model was used for statistical analysis. In the plane rectangular coordinate system, the forest plot takes a vertical invalid line (scale of abscissa is 0) as the center, describes the effect quantity and 95% CI of each study by using multiple line segments parallel to the horizontal axis, and describes the effect quantity and confidence interval of multiple studies by using a diamond. AEs, adverse events; SAEs, serious adverse events; MSCs, mesenchymal stem cells; CI, confidence interval

Back to article page